Very late drug-eluting stent thrombosis after nonsteroidal anti-inflammatory drug treatment despite dual antiplatelet therapy.
BACKGROUND
Drug-eluting coronary stent implantation emerged as a safe and effective therapeutic approach by preventing coronary restenosis and reducing the need for further revascularization. However, in contrast to bare metal stents, recent data suggest a unique underlying pathology, namely late coronary stent thrombosis and delayed endothelial healing.


OBJECTIVE
To report a case of very late coronary stent thrombosis (834 days after implantation) requiring repeat urgent target-vessel revascularization. Importantly, six days before the acute coronary event, combined nonsteroidal anti-inflammatory drug therapy was initiated.


RESULTS
Although a dual antiplatelet regimen was continuously maintained, aggregation measurements indicated only partial antiplatelet effect, which returned to the expected range when nonsteroidal anti-inflammatory drugs were omitted.


CONCLUSIONS
The observation indicates that, even 834 days after drug-eluting stent implantation, effective combined antiplatelet therapy might be crucial in certain individuals and the possible impact of drug interactions should not be underestimated. Further efforts should focus on the challenging task of identifying patients or medical situations with prolonged, increased risk of stent thrombosis.
Merkely
Bela
B
Heart Center, Semmelweis University, Budapest, Hungary.
Tóth-Zsamboki
Emese
E
Becker
David
D
Beres
Bernat Janos
BJ
Szabó
György
G
Vargova
Katarina
K
Fülöp
Gabor
G
Kerecsen
Gabor
G
Preda
Istvan
I
Spaulding
Christian
C
Kiss
Robert G
RG